SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950130-10-001450
Filing Date
2010-05-28
Accepted
2010-05-28 16:50:15
Documents
4
Effectiveness Date
2010-05-28

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS ddefa14a.htm DEFA14A 27203
2 GRAPHIC g74397tx001a.jpg GRAPHIC 2964
3 GRAPHIC g74397tx001b.jpg GRAPHIC 1923
4 GRAPHIC g74397tx003.jpg GRAPHIC 3934
  Complete submission text file 0000950130-10-001450.txt   41209
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-12465 | Film No.: 10867246
SIC: 2834 Pharmaceutical Preparations